FTSE MIB
34.249,77 +310,02 (+0,91%) Dow Jones
38.239,66 +153,86 (+0,40%) Nasdaq
15.927,90 +316,14 (+2,03%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
83,66 +0,09 (+0,11%) Bitcoin EUR
59.123,22 -680,20 (-1,14%)
Inari Medical, Inc. (NARI)
Dopo ore:
| Chiusura precedente | 38,07 |
| Aperto | 38,02 |
| Denaro | 38,38 x 100 |
| Lettera | 38,47 x 100 |
| Min-Max giorno | 37,97 - 38,97 |
| Intervallo di 52 settimane | 36,73 - 71,85 |
| Volume | |
| Media Volume | 1.218.319 |
| Capitalizzazione | 2,227B |
| Beta (5 anni mensile) | 0,85 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,03 |
| Prossima data utili | 30 apr 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 72,09 |
GlobeNewswireInari Medical to Announce Third Quarter 2023 Financial Results
IRVINE, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its third quarter 2023 financial results on Wednesday, November 1, 2023. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and
- GlobeNewswire
Inari Medical to Present at Upcoming Investor Conferences
IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the following investor conferences: 2023 Wells Fargo Healthcare ConferencePresenting on Friday, September 8, 2023 at 8:45 a.m. Eastern Time in Boston, MA at the Encore Boston Harbor 21st Annual Morgan Stanley Global Heal
- GlobeNewswire
Inari Medical Reports Second Quarter 2023 Financial Results
IRVINE, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its second quarter ended June 30, 2023. Second Quarter Financial and Recent Business Highlights Generated revenue of $119.0 million in Q2 of 2023, up 28.3% over the same quarter last year.Delivered net income of $2.1 million in Q2 of 2023,
